drugset / Trial / NCT00653172
Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare the efficacy, safety and tolerance of 2 different dose levels of oral NXL103 with oral comparator in the treatment of community acquired pneumonia in adults
Timeline
- Start
- 2007-10
- Primary completion
- 2008-06
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NXL103 | Unknown | 500 mg | Oral |
| Subject | NXL103 | Unknown | 600 mg | Oral |
Indications
No indication recorded.